Approval · Notice of Compliance 22754 · 2019
NEXGARD: Notice of Compliance 22754
Issued October 7, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22754
- Date
- October 7, 2019
- Company
- Boehringer Ingelheim Animal Health Canada Inc.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEXGARD | 02427451 | Marketed |
Medicinal ingredients
- AFOXOLANER 68 MG per TAB